This week’s newsletter covers the archaeological discovery of psychoactive drug use in an ancient Peruvian temple, a range of journalism examining CBD product quality and emerging therapeutic applications, and a research round-up spanning synthetic cannabinoids, breast cancer, metabolic health, and topical CBD medicine.
Noteworthy Read
Psychoactive Drugs Found in Mysterious Temple (Science.org)
Archaeologists have uncovered a 2,500-year-old ceremonial chamber in the Peruvian Andes, revealing early evidence of ritualistic use of psychoactive substances. The Chavín culture, predating the Inca civilization, used this hidden chamber for exclusive ceremonies involving hallucinogens. Artifacts such as hollowed-out bird bones, used as snuff tubes, contained residues indicating the inhalation of psychoactive substances during these rituals.
Read more
View more in Psychedelics
More Noteworthy Reading
CBD Oils: Do You Know What’s Inside? (High Plains Journal)
This article raises concerns about the quality and consistency of CBD oil products, citing independent lab tests that reveal discrepancies between product labels and actual cannabinoid content.
Study: Names of CBD Oil Products and Consumer Preferences (Labroots)
A new study finds that product names and branding significantly influence consumer preferences for CBD oils, with terms like “natural” and “therapeutic” increasing perceived effectiveness.
CBD for Dentistry? (Free Press Community Review)
This piece explores the emerging interest in CBD for dental care, particularly its potential as an anti-inflammatory and analgesic for patients with chronic oral health issues.
CBD for Therapeutic Dermatology (Dermatology Times)
Dermatologists are examining CBD’s potential role in treating inflammatory skin conditions such as eczema and psoriasis, though experts caution that clinical data is still limited.
Research Round-Up
Cannabinoids: Adaptogens or Not?
This paper explores whether cannabinoids meet the scientific criteria to be classified as adaptogens, substances that help the body resist physical, chemical, and biological stressors.
Read more
View more in Endocannabinoid System
Adverse Clinical Effects of Synthetic Cannabinoids
A review of clinical case studies details the serious and sometimes life-threatening adverse effects associated with synthetic cannabinoid use, including cardiovascular, neurological, and psychiatric complications.
Read more
View more in Synthetic Cannabinoids
CBD Therapy for Breast Cancer
This study investigates cannabidiol’s therapeutic potential in breast cancer treatment, highlighting its anti-tumor, anti-proliferative, and pro-apoptotic effects.
THCV for Diabetes and Weight Management
Researchers examine the metabolic effects of THCV, suggesting it may support blood sugar regulation and weight control, offering potential promise as a therapeutic option.
CBD Topical Medicine: What Does the Science Say? (Project CBD)
By Nate Seltenrich
From arthritis to skincare, scientists are beginning to uncover how topical CBD may reduce inflammation and pain — but more human studies are still needed. This article dives deep into the existing scientific research on transdermal cannabinoid medicine.
A heartfelt thank you to all of the CBD brands whose generous support fuels Project CBD’s mission to bring you the latest in plant medicine research and journalism — we couldn’t do this work without you.
